✦ LIBER ✦

A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane)

✍ Scribed by Brian B. Hasinoff; Theodore I. Kuschak; Jack C. Yalowich; Andrew M. Creighton

Book ID: 115784345
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 642 KB
Volume: 50
Category: Article
ISSN: 0006-2952
DOI: 10.1016/0006-2952(95)00218-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterisation of cytotoxicity and DNA

Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells

✍ Lars H Jensen; Marielle Dejligbjerg; Lasse T Hansen; Morten Grauslund; Peter B J 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 748 KB

## Background Bisdioxopiperazine anti-cancer agents are inhibitors of eukaryotic DNA topoisomerase II, sequestering this protein as a non-covalent protein clamp on DNA. It has been suggested that such complexes on DNA represents a novel form of DNA damage to cells. In this report, we characterise t

A comparative study of the cytotoxic and

A comparative study of the cytotoxic and genotoxic effects of ICRF-154 and bimolane, two catalytic inhibitors of topoisomerase II

✍ Minh C. Vuong; Leslie S. Hasegawa; David A. Eastmond 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 993 KB

Antagonistic effect of the cardioprotect

Antagonistic effect of the cardioprotector (+)-1,2-BIS(3,5-dioxopiperazinyl-1-YL)propane(ICRF-187) on dna breaks and cytotoxicity induced by the topoisomerase ii directed drugs daunorubicin and etoposide (VP-16)

✍ Maxwell Sehested; Peter Buhl Jensen; Boe Sandahl Sørensen; Bente Holm; Ellen Fri 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 520 KB